Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/14400
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMcGregor, C.en
dc.contributor.authorMachin, A.en
dc.contributor.authorWhite, J.en
dc.date.issued2003en
dc.identifier.citationDrug and Alcohol Review, 2003; 22(2):175-180en
dc.identifier.issn0959-5236en
dc.identifier.issn1465-3362en
dc.identifier.urihttp://hdl.handle.net/2440/14400-
dc.description.abstractFixed and symptom-triggered taper methods during in-patient benzodiazepine withdrawal treatment were compared using a randomized controlled design. Forty-four benzodiazepine users seeking in-patient withdrawal treatment at two substance use treatment clinics in Adelaide, Australia were recruited. Measurements included the Severity of Dependence Scale and the SF-36. A scale comprising six items from the Clinical Institute Withdrawal Assessment Scale—Benzodiazepines (CIWA-B) was used to measure withdrawal symptoms. Participants were randomized to receive a fixed diazepam tapering regime or diazepam only in response to withdrawal symptoms (symptom-triggered group). Results showed that there were no significant differences between treatment groups in terms of withdrawal severity, duration of in-patient treatment, amount of diazepam administered, treatment attrition and benzodiazepine use at follow-up. Both groups showed a reduction in benzodiazepine dosage of 86% over the first 8 days which was maintained at 1 month post-discharge. Although there were improvements in some subscales of the SF-36 between baseline and follow-up, values were significantly below age-matched norms at both time-points. This study showed that benzodiazepine users entering treatment have relatively poor health and that symptom-triggered taper methods incorporating flexible dosing and flexible treatment duration are as effective as fixed dose taper methods for in-patient benzodiazepine withdrawal treatment. [McGregor C, Machin A, White JM. In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods.en
dc.description.statementofresponsibilityCatherine McGregor, Alison Machin and Jason M. Whiteen
dc.language.isoenen
dc.publisherCarfax Publishingen
dc.subjectBenzodiazepine; CIWA-B; SF-36; taper; treatment; withdrawalen
dc.titleIn-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methodsen
dc.typeJournal articleen
dc.identifier.rmid0020030545en
dc.identifier.doi10.1080/09595230100100615en
dc.identifier.pubid58771-
pubs.library.collectionPharmacology publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
Appears in Collections:Pharmacology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.